Serum lipid profile in non-polycystic ovary syndrome and polycystic ovary syndrome women: a comparative and correlational study

Nimish R. Halasawadekar, Jaiprakash B. Ramanand, Sunita J. Ramanand, Girish T. Raparti, Praveenkumar T. Patil, Ruchi D. Shah, Arvind V. Kumbhar


Background: Polycystic ovary syndrome (PCOS), in addition to impaired ovulation, also affects metabolic pathways. Dyslipidemia, occurring in PCOS women leads to cardiovascular diseases in them. The purpose of the present study was to compare lipid profile and its correlation with biochemical and hormonal parameters in PCOS and non PCOS women, to analyse the correlation of lipid profile with hirsutism and body mass index (BMI) in PCOS women.

Methods: The present study includes 68 women divided into non PCOS groups (n=30) and PCOS (n=38) as defined by Rotterdam criteria. PCOS group further divided into overweight / obese (n=23) and normal weight subgroups (n=15). Lipid profile, fasting blood glucose and hormonal profile were done in all the groups.

Results: TG and TC/HDL ratio were significantly high in PCOS group. Hirsute patients had raised LDL levels as compared to non-hirsute. LDL showed positive significant correlation with insulin, HOMA, testosterone in PCOS group. TC was significantly positively correlated with insulin and HOMA in PCOS group. In both normal weight and overweight / obese PCOS subgroups, LDL had positive and significant correlation with testosterone. TC showed positive and significant correlation with HOMA in overweight/obese subgroup. HDL showed positive and highly significant correlation with FSH in normal weight PCOS.

Conclusions: Hyperandrogenism in PCOS may be additionally marked by raised LDL. Overweight/obese PCOS subgroup may be prone to dyslipidemia as well as deranged glucose homeostasis, thereby making it an important therapeutic target.


PCOS, Dyslipidemia, Correlation, Hirsuitism

Full Text:



Padubidre VG, Daftary SN. Disorders of Ovary. Shaw’s Text book of Gynaecology, 13th edition, Elsevier publishers. 2004:353-4.

Franks S. Polycystic ovary syndrome. New England J Medicine. 1995;333:853-61.

Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38(9):1165-74.

Kalra A, Nair S, Rai L. Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome. Indian J Med Sci. 2006;60(11):447-53.

Al-hakeim HK, Shaba’a SM, Kadheim MA. Is lipid profile in women with polycystic ovary syndrome related to calcium or magnesium in serum. Journal Kerbala University. 2009;7:150-7.

Guzick DS, Talbott EO, Sutton-Tyrrell K, Herzog HC, Kuller LH, Wolfson SK Jr. Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. Am J Obstet Gynecol. 1996;174(4):1224-9.

Birdsall MA, Farquhar CM, White HD. Association between polycystic ovaries and extent of coronary artery diseases in women having cardiac catheterization. Ann Intern Med. 1997;126:32-5.

Dahlgren E1, Janson PO, Johansson S, Lapidus L, Oden A. Ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study. Acta Obstet Gynecol Scand. 1992;71(8):559-604.

Rotterdam group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod. 2004;19(1):41-7.

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.

Ramanad SJ, Ramanad JB, Jain SS, Raparti GT, Ghanghas RR, Halasawadekar NR, et al. Leptin in non PCOS and PCOS women: a comparative study. Int J Basic Clin Pharmacol. 2014;3(1):186-93.

Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, et al. Consensus Statement for Diagnosis of Obesity, Abdominal Obesity and the Metabolic Syndrome for Asian Indians and Recommendations for Physical Activity, Medical and Surgical Management. JAPI. 2009;57:163-70.

Fulghesu A, Magnini R (2012). Obesity Related Lipid Profile and Altered Insulin Incretion in Adolescent with Policystic Ovary Syndrome, Dyslipidemia - From Prevention to Treatment, Prof. Roya Kelishadi (Ed.), ISBN: 978-953-307-904-2.

Abulhassan N, Dawlatly B, Hesham A, Abul Ela A, Abdel Kader N. Dyslipidemia and Insulin Resistance in Obese and Non-Obese Polycystic Ovarian Syndrome Women. Kasr el aini medical journal. 2007;13(1):107-16.

Jayasree R, Vijayalakshmi M. Altered lipid profile associated with polycystic ovarian syndrome women of Tamilnadu. The Bioscan. 2010;5(1):131-3.

Rajkhowa M, Neary RH, Kumpatla P, Game FL, Jones PW, Obhrai MS et al. Altered Composition of High Density Lipoproteins in Women with the Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 1997;82(10):3389-94.

Rocha MP, Marcondes JA, Barcellos CR, Hayashida SA, Curi DD, da Fonseca AM, et al. Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors. Gynecological Endocrinology. 2011;27(10):814-9.

Goldberg IRA. Clinical review Diabetic Dyslipidemia: Causes and Consequences. JCE & M. 2001;86:965-71.

Alexander CJ, Tangchitnob EP, Lepor NE. Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women. Reviews in Obstetrics and Gynecology. 2009;2(4):232-9.

Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, Chrousos GP. Pathophysiology and types of dyslipidemia in PCOS. Trends in Endocrinology & Metabolism. 2007;18(7):280-5.